[Validation of the JH-SEFAC Questionnaire on Knowledge on Insulin Management by Patients with Diabetes in Community Pharmacies].

IF 0.6 Q4 HEALTH POLICY & SERVICES Farmaceuticos Comunitarios Pub Date : 2024-10-10 eCollection Date: 2024-10-15 DOI:10.33620/FC.2173-9218.(2024).26
Joaquina Huarte-Royo, Inés Mera-Gallego, Rosa María Ríos-Quintás, José A Fornos-Pérez, J Carlos Andrés-Iglesias, N Floro Andrés-Rodríguez
{"title":"[Validation of the JH-SEFAC Questionnaire on Knowledge on Insulin Management by Patients with Diabetes in Community Pharmacies].","authors":"Joaquina Huarte-Royo, Inés Mera-Gallego, Rosa María Ríos-Quintás, José A Fornos-Pérez, J Carlos Andrés-Iglesias, N Floro Andrés-Rodríguez","doi":"10.33620/FC.2173-9218.(2024).26","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To review and validate a questionnaire on knowledge of injectable insulin management (JH-SEFAC) by patients with diabetes for use in community pharmacies.</p><p><strong>Methods: </strong>Study design: cross-sectional observational in Spanish community pharmacies during the first half of 2023. Inclusion criteria: patients with diabetes, of legal age, on insulin treatment. Questionnaire design: a nominal group of community pharmacists reviewed and piloted the initial questionnaire to determine its feasibility. It was approved by the CEIC of Aragón (PI22/375). Content validation: by a multidisciplinary group of experts in diabetes, using an ad hoc evaluation questionnaire of 10 questions (Likert scale of 1-5). Reliability: by means of the internal consistency index (Cronbach's alpha) and the intraclass correlation coefficient (ICC). Reproducibility (test/retest): the results of the questionnaire administered twice 2-3 weeks apart to the group of patients were compared. Pharmacists members of the SEFAC Diabetes Working Group collaborated. Sample: calculated in 127 subjects (95% CI and precision of 10%).</p><p><strong>Results: </strong>20 community pharmacies from 13 autonomous communities included 131 patients. The expert assessment was 4.52 out of 5 (90.4%). The Keiser-Meyer-Olkin test was 0.626 and Bartlett's test was significant (p<0.001). The Cronbach's alpha of the global questionnaire was 0.804 and the ICC was 0.902. The mean score of the questionnaire was 15.98 out of 31 points.</p><p><strong>Conclusions: </strong>The JH-SEFAC questionnaire was validated to evaluate the management of insulin injectables, providing community pharmacists with a valuable tool for therapeutic education.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"16 4","pages":"36-60"},"PeriodicalIF":0.6000,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11491918/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Farmaceuticos Comunitarios","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33620/FC.2173-9218.(2024).26","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/15 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To review and validate a questionnaire on knowledge of injectable insulin management (JH-SEFAC) by patients with diabetes for use in community pharmacies.

Methods: Study design: cross-sectional observational in Spanish community pharmacies during the first half of 2023. Inclusion criteria: patients with diabetes, of legal age, on insulin treatment. Questionnaire design: a nominal group of community pharmacists reviewed and piloted the initial questionnaire to determine its feasibility. It was approved by the CEIC of Aragón (PI22/375). Content validation: by a multidisciplinary group of experts in diabetes, using an ad hoc evaluation questionnaire of 10 questions (Likert scale of 1-5). Reliability: by means of the internal consistency index (Cronbach's alpha) and the intraclass correlation coefficient (ICC). Reproducibility (test/retest): the results of the questionnaire administered twice 2-3 weeks apart to the group of patients were compared. Pharmacists members of the SEFAC Diabetes Working Group collaborated. Sample: calculated in 127 subjects (95% CI and precision of 10%).

Results: 20 community pharmacies from 13 autonomous communities included 131 patients. The expert assessment was 4.52 out of 5 (90.4%). The Keiser-Meyer-Olkin test was 0.626 and Bartlett's test was significant (p<0.001). The Cronbach's alpha of the global questionnaire was 0.804 and the ICC was 0.902. The mean score of the questionnaire was 15.98 out of 31 points.

Conclusions: The JH-SEFAC questionnaire was validated to evaluate the management of insulin injectables, providing community pharmacists with a valuable tool for therapeutic education.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[社区药房糖尿病患者胰岛素管理知识JH-SEFAC问卷验证]。
目的审查并验证社区药房使用的糖尿病患者注射胰岛素管理知识问卷(JH-SEFAC):研究设计:2023 年上半年在西班牙社区药房进行横断面观察。纳入标准:法定年龄、接受胰岛素治疗的糖尿病患者。问卷设计:由社区药剂师组成的名义小组对初步问卷进行了审查和试用,以确定其可行性。阿拉贡 CEIC 批准了该问卷(PI22/375)。内容验证:由糖尿病领域的多学科专家组成的小组使用 10 个问题的特别评估问卷(1-5 级李克特量表)进行验证。可靠性:采用内部一致性指数(Cronbach's alpha)和类内相关系数(ICC)。可重复性(测试/重测):对该组患者进行两次问卷调查,每次间隔 2-3 周,比较调查结果。SEFAC 糖尿病工作组成员的药剂师参与了合作。结果:13 个自治区的 20 家社区药房共纳入 131 名患者。专家评估结果为 4.52 分(满分 5 分,占 90.4%)。Keiser-Meyer-Olkin 检验结果为 0.626,Bartlett's 检验结果为显著(pConclusions:经过验证,JH-SEFAC 问卷可用于评估胰岛素注射剂的管理,为社区药剂师提供了一个宝贵的治疗教育工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Farmaceuticos Comunitarios
Farmaceuticos Comunitarios HEALTH POLICY & SERVICES-
CiteScore
0.40
自引率
33.30%
发文量
351
审稿时长
5 weeks
期刊最新文献
[OBSERVAFARMA: construyendo el futuro de los servicios profesionales farmacéuticos desde el presente]. [Validation of the JH-SEFAC Questionnaire on Knowledge on Insulin Management by Patients with Diabetes in Community Pharmacies]. [Professional Pharmaceutical Care Services. A case report]. [Analysis and categorization of pharmacotherapeutic queries received at a Valencia Drug Information Center]. [The relevant role of caregivers of patients using opioid analgesics].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1